Tarsus Pharmaceuticals (TARS)

• Market cap: $3.39B
• 1 day: -0.67%
• 5 days: 3.95%
• 1 month: 18.35%
• 3 months: 37.48%
• 6 months: 90.15%
• Year to date: 44.99%
• 1 year: 52.45%
• 5 years: 230.82%
• 10 years: 288.53%
• Sector: Healthcare
• Industry: Biotechnology

About: Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Employees: 323